More than 175 biotechs adopt Veeva Basics for drug development ops
Go back to More than 175 biotechs adopt Veeva Basics for drug development ops| (NASDAQ: GPCR) | Delayed: 22.01 -0.87 (3.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.88 | 52 Week High | $ | |||
| Open | $23.00 | 52 Week Low | $ | |||
| Day High | $23.32 | P/E | N/A | |||
| Day Low | $21.77 | EPS | $ | |||
| Volume | 804,085 | |||||
| VEEVA SYSTEMS, Inc. (NYSE: VEEV) | Delayed: 320.55 +1.88 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $318.67 | 52 Week High | $42.58 | |||
| Open | $317.01 | 52 Week Low | $19.97 | |||
| Day High | $322.99 | P/E | 10,685.00 | |||
| Day Low | $316.08 | EPS | $0.03 | |||
| Volume | 1,430,438 | |||||



